{"nctId":"NCT00053677","briefTitle":"Drug Treatment for Pathologic Gambling Disorder","startDateStruct":{"date":"2002-12"},"conditions":["Gambling"],"count":83,"armGroups":[{"label":"Naltrexone","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Naltrexone"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Naltrexone","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Diagnostic and Statistical Manual IV criteria for Pathological Gambling Disorder\n* Moderate or severe gambling urge assessed by the Gambling Symptom Assessment Scale\n* No psychiatric drug use for 2 weeks or more\n* Score \\>= 5 on The South Oaks Gambling Screen\n* Hamilton Depression Rating Scale and Anxiety Rating score \\< 26. An increase (up to 10 points) of the scores is allowed unless the subject shows the risks of suicide.\n* Completion of complete blood count, urinalysis, liver and thyroid function tests, and pregnancy tests, with no evidence of significant lab abnormalities\n* Reliable birth control in women of child-bearing potential","healthyVolunteers":true,"sex":"ALL","minimumAge":"21 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Yale-Brown Obsessive Compulsive Scale for Pathological Gambling (PG-YBOCS)","description":"A gambling severity measure derived from the Yale-Brown Obsessive Compulsive Scale. It sums gambling urges and thoughts questions to make a total score. Total scores range from 0 to 40, which higher scores indicating more severe gambling symptoms (worse outcome).Administered every week for the first 8 weeks and every other week for the remaining 10 weeks. Final visit scores were the scores measured at the last visit for each participant; data from previous visits were not combined to compute this value.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16.9","spread":"6.60"},{"groupId":"OG001","value":"18.6","spread":"4.90"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.7","spread":"8.12"},{"groupId":"OG001","value":"12.9","spread":"9.31"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":58},"commonTop":["Nausea","Headache","Diarrhea","Dry Mouth","Dizziness"]}}}